EU gets more doses of Bavarian monkeypox vaccine

Content of the article

BRUSSELS — The European Union said on Wednesday it had secured an additional 170,920 doses of the monkeypox vaccine developed by biotech firm Bavarian Nordic amid concerns about the disease outbreak.

The new order more than doubles the EU’s vaccine supply, bringing the total number of doses purchased directly by the EU to nearly 335,000.

Content of the article

The additional doses will be available for delivery before the end of the year, while vaccines purchased earlier are being distributed, the European Commission said.

“Although we have seen the number of monkeypox cases decrease in the EU over the past few weeks, the threat has not passed and we cannot let our guard down,” said EU Health Commissioner Stella. Kyriakides.

Since the start of the outbreak, around 18,500 cases of monkeypox have been reported in EU countries and their partners Norway and Iceland. (Reporting by Francesco Guarascio @fraguarascio; editing by Jason Neely)